Skip to main content
. Author manuscript; available in PMC: 2016 Nov 23.
Published in final edited form as: Ann Surg Oncol. 2016 May 2;23(9):2874–2882. doi: 10.1245/s10434-016-5241-0

TABLE 4.

Demographics of thyroid patients according to development of postoperative hematoma

Characteristic No hematoma Hematoma p
No. of patients 2375 20
Age (years) 48.8 ± 0.3 54.6 ± 4.6 0.11
Patient gender
  Female 99.2 % 0.8 % 0.79
  Male 99.1 % 0.9 %
Extent of operation
  Unilateral 1044 (99.8 %) 2 (0.2 %) <0.01
  Bilateral 1226 (98.6 %) 17 (1.4 %)
  Extensive 105 (99.1 %) 1 (0.9 %)
  Reoperative neck 203 (98.5 %) 3 (1.5 %) 0.41
Antiplatelet use
  None 1943 (99.3 %) 14 (0.7 %) 0.01
  <325 mg aspirin 209 (99.5 %) 1 (0.5 %)
  ≥325 mg aspirin 188 (98.4 %) 3 (1.6 %)
  Clopidogrel 35 (94.6 %) 2 (5.4 %)
Anticoagulant use
  None 2311 (99.4 %) 15 (0.6 %) <0.001
  Oral 50 (96.2 %) 2 (3.8 %)
  Injectable 14 (82.4 %) 3 (17.6 %)
Use of either medication type
  None 1893 (99.8 %) 10 (0.5 %) <0.001
  One 471 (98.1 %) 9 (1.9 %)
  Both 11 (91.7 %) 1 (8.3 %)

Data are expressed as mean ± SEM or as n (%)